SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Share Buy-Back Programme

17 May 2024 09:56

RNS Number : 9130O
Rotork PLC
17 May 2024
 

 

Rotork plc

Share buy-back programme - Tranche 2

 

17 May 2024

 

As announced at the preliminary results on 5 March 2024, Rotork plc ('Rotork' or the 'Company') commenced a share buyback programme (the 'Programme') to repurchase ordinary shares of 0.5 pence each in the capital of the Company ('Ordinary Shares') of up to £50 million (excluding stamp duty and expenses). Our financial flexibility enables us to pursue strategic investments and we remain active in looking for suitable opportunities, consistent with our Growth+ strategy.

 

The first tranche of the Programme concluded in May 2024. The second tranche will be carried out through an irrevocable non-discretionary agreement with Morgan Stanley & Co. International Plc ('MS'), pursuant to which MS shall purchase Ordinary Shares as riskless principal (and not as agent of Rotork) for the subsequent sale on to, and purchase by, Rotork. The second tranche of the Programme will run from 17 May 2024 and end no later than 19 July 2024. The aggregate purchase price of all Ordinary Shares acquired under the second tranche of the Programme will be no greater than £10 million (excluding stamp duty and expenses). Any purchases under the Programme will take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at the Company's 2024 Annual General Meeting (the "2024 Authority"). The maximum number of Ordinary Shares that the Company is authorised to purchase under the 2024 Authority is 86,125,908 Ordinary Shares. MS will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Any Ordinary Shares purchased by the Company will be cancelled.

 

Any purchase of Ordinary Shares in relation to the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's 2024 Authority, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). Rotork will announce any market repurchases of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

Enquiries to:

 

Nick Hasell/Susanne Yule, FTI Consulting Tel: +44 (0)20 3727 1340

Andrew Carter, Investor Relations Director, Rotork Plc Tel: +44 (0) 1225 733 200

 

Legal Entity Identifier: 213800AH5RZIHGWRJ718

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFIFETEEIDLIS
Date   Source Headline
1st Mar 20243:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
13th Feb 20243:30 pmRNSDirector/PDMR Shareholding
1st Feb 202411:00 amRNSTotal Voting Rights
11th Jan 20243:30 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:00 amRNSTotal Voting Rights
20th Dec 20235:17 pmRNSDirector Declaration
13th Dec 20233:30 pmRNSDirector/PDMR Shareholding
13th Dec 202311:00 amRNSDirector Declaration
11th Dec 20233:30 pmRNSDirector/PDMR Shareholding
1st Dec 20233:30 pmRNSTotal Voting Rights
22nd Nov 20237:00 amRNSTrading Update
13th Nov 20233:30 pmRNSDirector/PDMR Shareholding
1st Nov 20233:00 pmRNSTotal Voting Rights
11th Oct 20233:30 pmRNSDirector/PDMR Shareholding
9th Oct 20233:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSTotal Voting Rights
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSDirectorate Change – CFO Transition
7th Sep 202311:45 amRNSDirectorate Change
4th Sep 20234:03 pmRNSTotal Voting Rights
14th Aug 20234:30 pmRNSDirector/PDMR Shareholding
8th Aug 20237:00 amRNS2023 Interim Results
1st Aug 20234:36 pmRNSTotal Voting Rights
11th Jul 20233:00 pmRNSDirector/PDMR Shareholding
3rd Jul 202311:30 amRNSTotal Voting Rights
29th Jun 202310:45 amRNSDirectorate Change
19th Jun 202311:00 amRNSDirector Declaration
14th Jun 20233:30 pmRNSHolding(s) in Company
13th Jun 20231:00 pmRNSDirector/PDMR Shareholding
8th Jun 202312:26 pmRNSTotal Voting Rights
15th May 20234:15 pmRNSDirector/PDMR Shareholding
2nd May 20233:15 pmRNSTotal Voting Rights
28th Apr 20233:45 pmRNSDirector/PDMR Shareholding
28th Apr 20233:22 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Update
12th Apr 20233:00 pmRNSDirector/PDMR Shareholding
6th Apr 20234:45 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:00 pmRNSTotal Voting Rights
29th Mar 20232:30 pmRNSDirector/PDMR Shareholding
27th Mar 20236:21 pmRNSDirector/PDMR Shareholding
24th Mar 20233:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20234:46 pmRNS2022 Annual Report and Notice of 2023 AGM
15th Mar 20234:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
13th Mar 20233:30 pmRNSDirector/PDMR Shareholding
7th Mar 202311:00 amRNSDirector/PDMR Shareholding
1st Mar 20233:00 pmRNSTotal Voting Rights
28th Feb 20237:00 amRNS2022 Preliminary Results
13th Feb 20233:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.